Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322101
Status:
COMPLETED
Last Update Posted:
2014-10-31
First Post:
2006-05-02
Brief Title:
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Myelodysplastic Syndromes |
| Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome |
| Acute Myeloid LeukemiaTransient Myeloproliferative Disorder |
| Adult Acute Myeloid Leukemia in Remission |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Childhood Acute Myeloid Leukemia in Remission |
| Childhood Myelodysplastic Syndromes |
| de Novo Myelodysplastic Syndromes |
| Myelodysplastic Syndrome With Isolated Del5q |
| MyelodysplasticMyeloproliferative Neoplasm Unclassifiable |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Secondary Acute Myeloid Leukemia |
Keywords: